Source: European Journal of Surgical Oncology. Conference titles: Congress of the European Society of Surgical Oncology (EJSO). Unidade: FMRP
Assunto: NEOPLASIAS MAMÁRIAS (QUIMIOTERAPIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARANA, H. et al. VEGF and HIF-1 alpha plasma level as prognostic factor in locally advanced breast cancer submitted to neoadjuvant chemotherapy. European Journal of Surgical Oncology. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 01 nov. 2024. , 2008APA
Marana, H., Tiezzi, D. G., Andrade, J. M., Garieri, A. P., Clagnan, W. S., Schiavon, V. F., & Silva, J. S. da. (2008). VEGF and HIF-1 alpha plasma level as prognostic factor in locally advanced breast cancer submitted to neoadjuvant chemotherapy. European Journal of Surgical Oncology. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.NLM
Marana H, Tiezzi DG, Andrade JM, Garieri AP, Clagnan WS, Schiavon VF, Silva JS da. VEGF and HIF-1 alpha plasma level as prognostic factor in locally advanced breast cancer submitted to neoadjuvant chemotherapy. European Journal of Surgical Oncology. 2008 ; 34( 9): 1056.[citado 2024 nov. 01 ]Vancouver
Marana H, Tiezzi DG, Andrade JM, Garieri AP, Clagnan WS, Schiavon VF, Silva JS da. VEGF and HIF-1 alpha plasma level as prognostic factor in locally advanced breast cancer submitted to neoadjuvant chemotherapy. European Journal of Surgical Oncology. 2008 ; 34( 9): 1056.[citado 2024 nov. 01 ]
